@prefix this: <https://w3id.org/np/RAG33Sh4VGucln5jEqjwjYSbcuO0LdhWpfHpJgeuEIIg4> .
@prefix sub: <https://w3id.org/np/RAG33Sh4VGucln5jEqjwjYSbcuO0LdhWpfHpJgeuEIIg4/> .
@prefix np: <http://www.nanopub.org/nschema#> .
@prefix dct: <http://purl.org/dc/terms/> .
@prefix npx: <http://purl.org/nanopub/x/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix orcid: <https://orcid.org/> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix fip: <https://w3id.org/fair/fip/terms/> .
@prefix prov: <http://www.w3.org/ns/prov#> .

<https://w3id.org/np/RAG33Sh4VGucln5jEqjwjYSbcuO0LdhWpfHpJgeuEIIg4> a np:Nanopublication;
  np:hasAssertion sub:assertion;
  np:hasProvenance sub:provenance;
  np:hasPublicationInfo sub:pubinfo;
  dct:created "2025-11-17T12:31:17Z"^^xsd:dateTime;
  dct:creator <https://fip.fair-wizard.com/wizard>;
  dct:license <https://creativecommons.org/publicdomain/zero/1.0/>;
  npx:introduces <https://w3id.org/np/RALyCqVS2HL0PjqQgyItKVn7pGaSNlj4qsO0M4juZSZf8#ACTG-portal>;
  npx:supersedes <https://w3id.org/np/RALyCqVS2HL0PjqQgyItKVn7pGaSNlj4qsO0M4juZSZf8>;
  prov:wasDerivedFrom <https://w3id.org/fip/wizard/69d40df3-ffda-4694-b08b-61c8a28dbf3e> .

<https://w3id.org/np/RALyCqVS2HL0PjqQgyItKVn7pGaSNlj4qsO0M4juZSZf8#ACTG-portal> a
    fip:Available-FAIR-Supporting-Resource, fip:Domain-Specific-Registry, fip:FAIR-Enabling-Resource,
    fip:Registry;
  <http://schema.org/url> <https://actgnetwork.org/clinical-trial/?site_search=&research_area=&site_status=#search-form>;
  rdfs:comment "ACTG is a global clinical trials network that conducts research to improve the management of HIV and its comorbidities; develop a cure for HIV; and innovate treatments for tuberculosis, hepatitis B, and emerging infectious diseases.";
  rdfs:label "Advancing Clinical Therapeutics Globally Portal";
  fip:has-description-source <https://actgnetwork.org/> .

sub:assertion dct:creator orcid:0009-0003-5409-652X .

sub:sig npx:hasAlgorithm "RSA";
  npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCoKFb7LKlXyBB7BUvjFF9bDJNk0WxH3Xerr4H3v/VCiRVshEDl3BZVekbMMmdRe+TOPyc8AOLd9IAL2VfVVD/T0rmCHk7Pw7DQjI96mwyeXhE7f4g0WG5UT5Pxxm0Rzy7IrYnEaaVDs7dkZUt952M6qWlHfTwCQDcXJhZfLiXoMwIDAQAB";
  npx:hasSignature "WGb4mdY9ZOMrOPP9pN+R9CZy+vPCWPBGGZBT8YpR69qtFoH7GwWwLIZezLGmZjh3nw2TLGr4Jar1J+ODSPCFm9KJQD1rGoNogAKq7FIcm/8LWy+HGqrAHzfLcgxJGeuWq+P1jvM2kUL26aLDdYSniQqO458AMDuBidRylGG2D0I=";
  npx:hasSignatureTarget <https://w3id.org/np/RAG33Sh4VGucln5jEqjwjYSbcuO0LdhWpfHpJgeuEIIg4> .

